Quality & complianceOfficial
Infarmed orders recall of Entecavir Viatris batches over active substance manufacturing concerns
🇵🇹 INFARMED · Thu 19 Nov 2026
Portugal's medicines authority has halted distribution of the listed batches after a counterpart regulator found active substance manufacturing issues linked to potential contamination and cross-contamination.
Infarmed, Portugal's medicines regulator, has ordered the recall of Entecavir Viatris medicines and the immediate suspension of distribution of the batches listed in an annex to Circular Informativa n.º 108/CD/550.20.001, dated 19 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.
More Quality & compliance
All →
Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk
🇨🇦 Health Canada · Fri 20 Nov 2026
FDA says clinical investigator's CAPA response falls short after CBER warning letter
🇺🇸 FDA CBER · Fri 20 Nov 2026
BfArM publishes GE Healthcare urgent field safety notice for Centricity PACS and Enterprise Archive
🇩🇪 BfArM field safety notices · Fri 20 Nov 2026
New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice
🇺🇸 HHS OIG · Fri 20 Nov 2026
Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m
🇺🇸 HHS OIG · Fri 20 Nov 2026
InnovAge settles Colorado Medicaid false claims allegations over senior care services
🇺🇸 HHS OIG · Fri 20 Nov 2026